AngioDynamics Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 AngioDynamics Inc 公司

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

AngioDynamics Inc简介



公司代码ANGO

公司名称AngioDynamics Inc

上市日期May 27, 2004

CEOClemmer (James C)

员工数量675

证券类型Ordinary Share

年结日May 27

公司地址14 Plaza Drive

城市LATHAM

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编12110

电话15187981215

网址https://www.angiodynamics.com/

公司代码ANGO

上市日期May 27, 2004

CEOClemmer (James C)

AngioDynamics Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Stephen A. Trowbridge, J.D.

Chief Financial Officer, Executive Vice President

323.32K

+890.00%

Mr. Howard W. Donnelly

Independent Non-Executive Chairman of the Board

167.05K

--

Ms. Eileen O'Shea Auen

Independent Director

129.72K

--

Ms. Laura Piccinini

Senior Vice President, General Manager - Endovascular Therapies and International

102.52K

-36233.00%

Mr. Wesley E. Johnson, Jr.

Independent Director

--

Mr. James C. Clemmer

President, Chief Executive Officer, Director

--

Ms. Jan Stern Reed

Independent Director

--

Mr. Warren G. Nighan

Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs

--

Mr. Chad T. Campbell

Senior Vice President, General Manager - Global Oncology and Vascular Access

--

Ms. Karen A. Licitra

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Stephen A. Trowbridge, J.D.

Chief Financial Officer, Executive Vice President

323.32K

+890.00%

Mr. Howard W. Donnelly

Independent Non-Executive Chairman of the Board

167.05K

--

Ms. Eileen O'Shea Auen

Independent Director

129.72K

--

Ms. Laura Piccinini

Senior Vice President, General Manager - Endovascular Therapies and International

102.52K

-36233.00%

Mr. Wesley E. Johnson, Jr.

Independent Director

--

Mr. James C. Clemmer

President, Chief Executive Officer, Director

--

收入明细

单位: USD更新时间: 1月6日周二

FY2026Q1

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2021

FY2020

FY2019

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

United States

66.46M

87.78%

International

9.26M

12.22%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 2月4日周三

持股股东

股东类型

持股股东

占比

Divisadero Street Capital Management, LP

8.92%

BlackRock Institutional Trust Company, N.A.

7.04%

Systematic Financial Management, L.P.

6.24%

Point72 Asset Management, L.P.

6.21%

The Vanguard Group, Inc.

5.91%

其他

65.68%

持股股东

占比

Divisadero Street Capital Management, LP

8.92%

BlackRock Institutional Trust Company, N.A.

7.04%

Systematic Financial Management, L.P.

6.24%

Point72 Asset Management, L.P.

6.21%

The Vanguard Group, Inc.

5.91%

其他

65.68%

股东类型

持股股东

占比

Investment Advisor

35.12%

Investment Advisor/Hedge Fund

34.15%

Hedge Fund

19.12%

Individual Investor

6.43%

Venture Capital

3.46%

Research Firm

2.32%

Pension Fund

1.68%

Bank and Trust

0.25%

Insurance Company

0.03%

机构持股



更新时间: 12月8日周一

报告期

机构数

持股数

持股占比

持股变动

2025Q4

318

39.75M

96.45%

-4.83M

2025Q3

344

40.20M

109.06%

+1.51M

2025Q2

370

37.97M

110.38%

+1.85M

2025Q1

372

36.50M

106.59%

-6.63M

2024Q4

361

34.34M

98.76%

+1.35M

2024Q3

371

33.44M

109.60%

-216.03K

2024Q2

370

33.66M

118.59%

-3.23M

2024Q1

368

36.03M

115.74%

-10.10M

2023Q4

378

37.01M

114.23%

+355.36K

2023Q3

364

36.64M

109.90%

-219.51K

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Divisadero Street Capital Management, LP

3.68M

8.92%

+282.69K

+8.33%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

2.90M

7.04%

-61.07K

-2.06%

Sep 30, 2025

Systematic Financial Management, L.P.

2.57M

6.24%

+60.60K

+2.41%

Sep 30, 2025

Point72 Asset Management, L.P.

2.56M

6.21%

+609.91K

+31.29%

Sep 30, 2025

The Vanguard Group, Inc.

2.36M

5.74%

-125.09K

-5.03%

Sep 30, 2025

Armistice Capital LLC

1.64M

3.97%

+108.19K

+7.08%

Sep 30, 2025

Segall Bryant & Hamill, LLC

1.32M

3.2%

-37.14K

-2.74%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.16M

2.8%

-16.92K

-1.44%

Sep 30, 2025

Clemmer James C

1.13M

2.74%

+10.00K

+0.89%

Oct 09, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

State Street SPDR S&P Health Care Equipment ETF

0.79%

Invesco NASDAQ Future Gen 200 ETF

0.63%

Vanguard US Multifactor ETF

0.15%

iShares Micro-Cap ETF

0.09%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.08%

Invesco Russell 2000 Dynamic Multifactor ETF

0.07%

Fidelity Enhanced Small Cap ETF

0.06%

Avantis US Small Cap Equity ETF

0.06%

Invesco RAFI US 1500 Small-Mid ETF

0.04%

iShares Russell 2000 Value ETF

0.02%

State Street SPDR S&P Health Care Equipment ETF

占比0.79%

Invesco NASDAQ Future Gen 200 ETF

占比0.63%

Vanguard US Multifactor ETF

占比0.15%

iShares Micro-Cap ETF

占比0.09%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

占比0.08%

Invesco Russell 2000 Dynamic Multifactor ETF

占比0.07%

Fidelity Enhanced Small Cap ETF

占比0.06%

Avantis US Small Cap Equity ETF

占比0.06%

Invesco RAFI US 1500 Small-Mid ETF

占比0.04%

iShares Russell 2000 Value ETF

占比0.02%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据